LifeVantageLFVN
Market Cap: $131M
About: Lifevantage Corp is engaged in the identification, research, development, and distribution of nutraceutical dietary supplements and skincare products. It offers products such as Protandim, a scientifically-validated dietary supplement; LifeVantage TrueScience, an anti-aging skincare product; Axio energy drink mixes; and PhysIQ, a weight management system, as well as Canine Health, a companion pet supplement formulated to combat oxidative stress in dogs. Geographically, its products are sold in the regions of the United States, Japan, Hong Kong, Australia, Canada, Philippines, Mexico, Thailand, the United Kingdom, and the Netherlands.
Employees: 248
Fund manager confidence
Based on 2024 Q2 SEC filings by fund managers ($100M+ AUM)
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
6% more funds holding
Funds holding: 52 [Q1] → 55 (+3) [Q2]
3% more capital invested
Capital invested by funds: $18.4M [Q1] → $19M (+$566K) [Q2]
0.26% less ownership
Funds ownership: 23.63% [Q1] → 23.36% (-0.26%) [Q2]
20% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 15
67% less call options, than puts
Call options by funds: $1K | Put options by funds: $3K
Research analyst outlook
We haven’t received any recent analyst ratings for LFVN.
Financial journalist opinion
Based on 6 articles about LFVN published over the past 30 days